Equities research analysts at William Blair cut their Q4 2025 earnings per share estimates for shares of Karooooo in a report ...
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
Investment analysts at William Blair assumed coverage on shares of Sterling Infrastructure (NASDAQ:STRL – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. The ...
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
Procept Biorobotics Corp (PRCT) stock saw a decline, ending the day at $76.02 which represents a decrease of $-2.82 or -3.58% from the prior close of $78.84. The stock opened at $79.26 and touched a ...
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
Research analysts at William Blair issued their Q2 2025 EPS estimates for shares of Affirm in a research report issued to ...